Standard Treatment Option in Stage III Non–Small-Cell Lung Cancer: Case Against Trimodal Therapy and Consolidation Drug Therapy
Author:
Funder
Serbian Ministry of Education and Science
Publisher
Elsevier BV
Subject
Cancer Research,Pulmonary and Respiratory Medicine,Oncology
Reference57 articles.
1. Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non–small-cell lung cancer;Aupérin;J Clin Oncol,2010
2. Concurrent chemoradiotherapy in non–small cell lung cancer;O'Rourke;Cochrane Database Syst Rev,2010
3. Chemo-radiotherapy for advanced non–small cell lung cancer: concurrent or sequential? It's no longer the question: a systematic review;Liang;Int J Cancer,2010
4. Randomized trial of neoadjuvant therapy for lung cancer: interim analysis;Pass;Ann Thorac Surg,1992
5. A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non–small-cell lung cancer;Rosell;N Engl J Med,1994
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Consolidation Systemic Therapy in Locally Advanced, Inoperable Nonsmall Cell Lung Cancer—How to Identify Patients Which Can Benefit from It?;Current Oncology;2022-10-31
2. Postoperative radiotherapy for patients with completely resected pathological stage IIIA-N2 non-small cell lung cancer: a preferential benefit for squamous cell carcinoma;Radiology and Oncology;2020-12-03
3. Treatment patterns and real-world evidence for stage III non-small cell lung cancer in Central and Eastern Europe;Radiology and Oncology;2020-10-11
4. MiR-26a-5p Serves as an Oncogenic MicroRNA in Non-Small Cell Lung Cancer by Targeting FAF1;Cancer Management and Research;2020-08
MiR-26a-5p Serves as an Oncogenic MicroRNA in Non-Small Cell Lung Cancer by Targeting FAF1
5. Immuno-Oncology—The New Paradigm of Lung Cancer Treatment;Current Oncology;2020-04-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3